设为首页 加入收藏

TOP

Relizorb(iMMOBILIZED脂肪酶)药筒获美国FDA扩大批准使用范围,用于2至5岁儿童患者(二)
2025-05-10 17:03:39 来源: 作者: 【 】 浏览:81次 评论:0
om your healthcare professional on how long it should take you to complete your tube feeding.
Ensure all inlet and outlet connectors on RELiZORB and enteral feeding supplies are clean and dry prior to making connections.
In order to ensure product performance, store RELiZORB in its pouch either refrigerated or at room temperature (2°C to 27°C; 36°F to 80°F).
RELiZORB is indicated for use with enteral feeding only; patients should follow physician’s guidance for pancreatic enzyme replacement therapy (PERT) use for meals and snacks. Patients and patient caregivers should follow physician’s guidance regarding the need for pancreatic enzyme replacement therapy (PERT) during enteral feeding. 

Tags: 责任编辑:admin
首页 上一页 1 2 下一页 尾页 2/2/2
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇美国FDA批准Penpulimab-kcqx,联.. 下一篇新药Avmapki联合Fakzynja获FDA加..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位